| 货号 | 1236/100 |
| 别名 | 1,4-Dihydroxy-2,5-di-tert-butylbenz |
| 供应商 | Tocris |
| 生物活性 | A selective inhibitor of endoplasmic reticulum Ca2+-ATPase. |
| 运输条件 | Blue Ice |
| 存放说明 | Ambient |
| 计算分子量 | 222.33 |
| 分子式 | C14H22O2 |
| 可溶性/溶解性 | Soluble to 100 mM in DMSO |
| CAS号 | 88-58-4 |
| 参考文献 | Dettbarn and Palade (1999) Effects of three sarcoplasmic/endoplasmic Ca++ pump inhibitors on release channels and intracellular stores. J.Pharmacol.Exp.Ther. 285 739. PMID: 9580621. Fusiet al (1999) 2,5-Di-t-butyl-1,4 benzohydroquinone induces endothelium-dependent relaxation of rat thoracic aorta. Eur.J.Pharmacol. 366 181. PMID: 10082199. Janet al (1999) Mechanism of rise and decay of 2,5-di-tert-butylhydroquinone-induced Ca2+ signals in Madin Darby canine kidney cells. Eur.J.Pharmacol. 365 111. PMID: 9988129. Hassessianet al (1994) Blockade of the inward rectifier potassium current by the Ca2+-ATPase inhibitor 2',5'-di(tert-butyl)-1,4-benzohydroquinone (BHQ). Br.J.Pharmacol. 112 1118. PMID: 7952872. |